封面
市场调查报告书
商品编码
1087040

全球组织银行市场预测(2022-2027)

Tissue Banking Market - Forecasts from 2022 to 2027

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球组织银行市场预计将从 2020 年的 24.54 亿美元增长到 2027 年的 33.74 亿美元,预测期内的复合年增长率为 4.65%。

研发部门的新鲜样本和组织需求为全球组织银行市场的增长提供了潜力。此外,市场公司对细胞和组织再生领域的开发和研究的投资,以及依赖组织库的医院和卫生研究机构正在支持全球组织库市场的增长。此外,越来越多的慢性病病例和基于组织再生的治疗也增加了组织库在全球市场的市场价值。此外,政府和政府的支持正在促进全球组织银行市场的增长。

本报告研究和分析全球组织银行市场,并提供市场概况、市场动态、市场分析、竞争形势和公司概况等系统信息。

目录

第一章介绍

  • 市场定义
  • 市场细分

第二章调查方法

  • 调查数据
  • 先决条件

第 3 章执行摘要

  • 调查重点

第四章市场动态

  • 市场促进因素
  • 市场製约因素
  • 波特五力分析
    • 终端用户议价能力
    • 买方的议价能力
    • 新进入者的威胁
    • 替代威胁
    • 业内竞争对手之间的敌对关係
  • 产业价值链分析

第 5 章世界组织银行业市场分析:按组织类型

  • 简介
  • 角膜
  • 皮肤
  • 骨头
  • 心臟瓣膜
  • 软组织
  • 脐带

第 6 章世界银行银行市场分析:按用途

  • 简介
  • 治疗
  • 研发
  • 其他

第 7 章世界银行银行市场分析:按地区

  • 简介
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 其他
  • 中东/非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 台湾
    • 泰国
    • 印度尼西亚
    • 其他

第8章竞争环境与分析

  • 主要公司及战略分析
  • 初创企业和市场盈利能力
  • 合併/收购/协议/联盟
  • 供应商竞争矩阵

第 9 章公司简介

  • Hamilton Company
  • IMA Pharma
  • Life Link Tissue Bank
  • Merck KgaA
  • PHC Europe B.V.
  • Tata Memorial Hospital-Tissue Bank
  • Tecan Group Ltd.
  • The PXE International Blood and Tissue Bank
  • Thermo Fisher Scientific, Inc.
  • TuBaFrost Group
  • Versity
简介目录
Product Code: KSI061612978

The global tissue banking market is evaluated at US$2.454 billion for the year 2020 and is projected to grow at a CAGR of 4.65% to reach a market size of US$3.374 billion by the year 2027.

A tissue bank is considered a certain type of bank that collects fresh specimens and tissue for future needs. The tissue bank is considered one of the leading specimen or tissue storage systems in the world. The medical field and research and development sectors are presently widely seeking the application and help of tissue banks. The need for fresh specimens and tissues in the research and development sector is giving potential to the growth of the global tissue bank market. The market players' investment in the development and research in the cell and tissue regeneration field are also driving the growth of the global tissue bank market. The medical sector and hospitals are also widely seeking the support and assistance of tissue banks for the treatment of certain chronic disorders. Hospitals and health research institutions relying on tissue banks are boosting the market growth of global tissue banks. The rising cases of chronic diseases like cancer etc. and their treatment based on tissue regeneration are also boosting the market value of tissue banks in the global market. The support offered by governments and government organizations is also contributing to the growth of the global tissue banking market.

The recent outbreak of the COVID-19 pandemic has adversely affected the market growth of the global tissue banking market. The ongoing research and developments conducted on tissues were halted due to the lockdowns and strict COVID-19 restrictions imposed by the government in order to prevent the spread of the coronavirus. The focus of the government and the medical field on preventing COVID spread resulted in less focus on and slow growth of the global tissue banking market in the pandemic period. The limited availability of practitioners and employees in the tissue banking sector also restricted the growth of the global tissue banking market to a certain extent. The high economic crisis that arose due to the COVID-19 pandemic also negatively influenced the economic stability of countries, restricting the growth of the tissue banking sector in each country, as the tissue banking systems have high expenditure and maintenance costs.

The demand for tissues for the treatment of chronic diseases

The rising demand for tissues for treating chronic diseases is increasing the market value of the global tissue banking sector. A tissue bank is a collection of various specimens and fresh tissues and is a relatively new discovery in the medical field that employs tissue for the treatment of chronic diseases and is boosting the growth of the global tissue banking system. According to the "American Association of Tissue Banks", the tissue banking network in the United States is exhibiting steady growth, with approximately 58 accredited tissue banks working in the United States alone. The tissue banks working in the United States are also properly certified and accredited by the FDA (Food and Drug Administration) of the United States. The government of the U.S. has been encouraging the use of tissue banks. According to the report of AATB (American Association of Tissue Banks), blood tissues or blood cells account for the major share of the global tissue banking market. The need for fresh specimens and the tissue in the treatment of chronic disorders and regeneration of tissue cells is driving the growth of the global tissue banking market.

Rising research and development

The growing trend of research and developments in tissue regeneration and the use of tissue in efficiently treating chronic diseases is boosting the growth of the global tissue banking market. Discoveries of stem cells in developing any other tissue is one of the latest innovations in the medical or health research sector. The discoveries like stem cells and others are fuelling the market growth of tissue banking in the global market. The investment of major players like Allergan and Hamilton Companies is boosting the applications and developments in tissue engineering. The wide research and developments in tissue engineering and employing tissue for treating chronic diseases are contributing to the market growth.

North America has the largest market share

Geographically, the North American region is has the largest share in the global tissue banking market. The presence of a large number of tissue banks and increasing research and development in the tissue engineering sector is leading to growth in the North American region in the tissue banking market. The presence of major market players and the rising number of chronic diseases are also driving the market growth in the North American tissue banking market.

Market Segmentation

  • By Tissue Type

Cornea

Skin

Bones

Heart Valves

Blood

Soft Tissues

Umbilical Cord

  • By Application

Therapeutic

Research and development

Others

  • By Geography

North America

  • USA
  • Canada
  • Mexico

South America

  • Brazil
  • Argentina
  • Others

Europe

  • Germany
  • France
  • UK
  • Others

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Others

Asia Pacific

  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation

2. Research Methodology

  • 2.1. Research Data
  • 2.2. Assumptions

3. Executive Summary

  • 3.1. Research Highlights

4. Market Dynamics

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porters Five Forces Analysis
    • 4.3.1. Bargaining Power of End-Users
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. Global Tissue Banking Market Analysis, by Tissue Type

  • 5.1. Introduction
  • 5.2. Cornea
  • 5.3. Skin
  • 5.4. Bones
  • 5.5. Heart Valves
  • 5.6. Blood
  • 5.7. Soft Tissues
  • 5.8. Umbilical Cord

6. Global Tissue Banking Market Analysis, by Application 

  • 6.1. Introduction
  • 6.2. Therapeutic
  • 6.3. Research and development
  • 6.4. Others

7. Global Tissue Banking Market Analysis, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. UK
    • 7.4.4. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Taiwan
    • 7.6.6. Thailand
    • 7.6.7. Indonesia
    • 7.6.8. Others

8. Competitive Environment and Analysis

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Emerging Players and Market Lucrativeness
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Vendor Competitiveness Matrix

9. Company Profiles 

  • 9.1. Hamilton Company
  • 9.2. IMA Pharma
  • 9.3. Life Link Tissue Bank
  • 9.4. Merck KgaA
  • 9.5. PHC Europe B.V.
  • 9.6. Tata Memorial Hospital - Tissue Bank
  • 9.7. Tecan Group Ltd.
  • 9.8. The PXE International Blood and Tissue Bank
  • 9.9. Thermo Fisher Scientific, Inc.
  • 9.10. TuBaFrost Group
  • 9.11. Versity